Is the Leptin/Adiponectin Ratio a Better Diagnostic Biomarker for Insulin Resistance than Leptin or Adiponectin Alone in Adolescents?
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Sample
2.2. Ethical and Legal Requirements
2.3. Measures
2.3.1. Anthropometrics
2.3.2. Pubertal Stage
2.3.3. Blood Sampling
2.3.4. Adherence to the Mediterranean Diet
2.3.5. Cardiorespiratory Fitness
2.3.6. Statistical Analysis
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Hansson, G.K. Mechanisms of disease: Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352, 1685–1695. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Koh, K.K.; Park, S.M.; Quon, M. Leptin and Cardiovascular Disease response to therapeutic interventions. Circulation 2008, 117, 3238–3249. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sáinz, N.; Barrenetxe, J.; Moreno-Aliaga, M.J.; Martínez, J.A. Leptin resistance and diet-induced obesity: Central and peripheral actions of leptin. Metabolism 2014, 64, 35–46. [Google Scholar] [CrossRef]
- Dâmaso, A.R.; de Piano, A.; Sanches, P.L.; Corgosinho, F.; Tock, L.; Oyama, L.M.; Tock, L.; Nascimento, C.M.O.D.; Tufik, S.; de Mello, M.T. Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss. Peptides 2011, 32, 1384–1391. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ai, M.; Otokozawa, S.; Asztalos, B.F.; White, C.C.; Cupples, L.A.; Nakajima, K.; Lamon-Fava, S.; Wilson, P.W.; Matsuzawa, Y.; Schaefer, E.J. Adiponectin: An independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis 2011, 217, 543–548. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, Y.-L.; Liang, H.-R.; Liu, H.-T.; Li, S.-Y.; Zhou, Y.-Y.; Cheng, H.-L.; Zhou, L.-S. Association of serum adiponectin levels with artherosclerosis and the metabolic syndrome in obese children. J. Pediatr. Endocrinol. Metab. 2010, 23, 743–751. [Google Scholar] [CrossRef] [PubMed]
- López-Jaramillo, P.; Gómez-Arbeláez, D.; López-López, J.; López-López, C.; Martínez-Ortega, J.; Gómez-Rodríguez, A.; Triana-Cubillos, S. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm. Mol. Biol. Clin. Investig. 2014, 18, 37–45. [Google Scholar] [CrossRef] [Green Version]
- Oda, N.; Imamura, S.; Fujita, T.; Uchida, Y.; Inagaki, K.; Kakizawa, H.; Hayakawa, N.; Suzuki, A.; Takeda, J.; Horikawa, Y.; et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 2008, 57, 268–273. [Google Scholar] [CrossRef]
- Norata, G.D.; Raselli, S.; Grigore, L.; Garlaschelli, K.; Dozio, E.; Magni, P.; Catapano, A.L. Leptin:Adiponectin Ratio Is an Independent Predictor of Intima Media Thickness of the Common Carotid Artery. Stroke 2007, 38, 2844–2846. [Google Scholar] [CrossRef] [Green Version]
- Zaletel, J.; Barlovic, D.P.; Prezelj, J. Adiponectin-leptin ratio: A useful estimate of insulin resistance in patients with Type 2 diabetes. J. Endocrinol. Investig. 2010, 33, 514–518. [Google Scholar] [CrossRef]
- Falahi, E.; Rad, A.H.K.; Roosta, S. What is the best biomarker for metabolic syndrome diagnosis? Diabetes Metab. Syndr. Clin. Res. Rev. 2015, 9, 366–372. [Google Scholar] [CrossRef] [PubMed]
- Calero, M.L.B.; Varela, J.M.A. Infant-juvenile type 2 diabetes. Rev. Clin. Esp. 2018, 218, 372–381. [Google Scholar] [CrossRef] [PubMed]
- Smolen, J.S.; Burmester, G.R.; Combeet, B.; NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4· 4 million participants. Lancet 2016, 387, 1513–1530. [Google Scholar]
- Frankenberg, A.D.v.; Reis, A.F.; Gerchman, F. Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: A literature review. Arch. Endocrinol. Metab. 2017, 61, 614–622. [Google Scholar] [CrossRef] [Green Version]
- Yoon, J.H.; Park, J.K.; Oh, S.S.; Lee, K.H.; Kim, S.K.; Cho, I.J.; Kim, J.K.; Kang, H.T.; Ahn, S.G.; Lee, J.W.; et al. The ratio of serum leptin to adiponectin provides adjunctive information to the risk of metabolic syndrome beyond the homeostasis model assessment insulin resistance: The Korean Genomic Rural Cohort Study. Clin. Chim. Acta 2011, 412, 2199–2205. [Google Scholar] [CrossRef]
- Ortega, F.B.; Ruiz, J.R.; Castillo, M.J.; Sjöström, M. Physical fitness in childhood and adolescence: A powerful marker of health. Int. J. Obes. 2008, 32, 1–11. [Google Scholar] [CrossRef] [Green Version]
- Huang, K.-C.; Lin, R.; Kormas, N.; Lee, L.-T.; Chen, C.-Y.; Gill, T.P.; Caterson, I.D. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents. Int. J. Obes. 2004, 28, 470–475. [Google Scholar] [CrossRef]
- Schwingshackl, L.; Hoffmann, G. Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 929–939. [Google Scholar] [CrossRef]
- Casas, R.; Sacanella, E.; Estruch, R. The immune protective effect of the Mediterranean diet against chronic low-grade inflam-matory diseases. Endocr. Metab Immune Disord. Drug Targets 2014, 14, 245–254. [Google Scholar] [CrossRef] [Green Version]
- Agostinis-Sobrinho, C.; Santos, R.; Moreira, C.; Abreu, S.; Lopes, L.; Oliveira-Santos, J.; Rosário, R.; Póvoas, S.; Mota, J. Association between serum adiponectin levels and muscular fitness in Portuguese adolescents: LabMed Physical Activity Study. Nutr. Metab. Cardiovasc. Dis. 2016, 26, 517–524. [Google Scholar] [CrossRef] [Green Version]
- Tanner, J.M.; Whitehouse, R.H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch. Dis. Child. 1976, 51, 170–179. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- A Agostinis-Sobrinho, C.; Ramírez-Vélez, R.; García-Hermoso, A.; Moreira, C.; Lopes, L.; Oliveira-Santos, J.; Abreu, S.; Mota, J.; Santos, R. Low-grade inflammation and muscular fitness on insulin resistance in adolescents: Results from LabMed Physical Activity Study. Pediatr. Diabetes 2017, 19, 429–435. [Google Scholar] [CrossRef] [PubMed]
- Serra-Majem, L.; Ribas, L.; Ngo, J.; Ortega, R.M.; García, A.; Pérez-Rodrigo, C.; Aranceta, J. Food, youth and the Mediterranean diet in Spain. Development of KIDMED, Mediterranean Diet Quality Index in children and adolescents. Public Heal. Nutr. 2004, 7, 931–935. [Google Scholar] [CrossRef] [PubMed]
- Léger, L.A.; Mercier, D.; Gadoury, C.; Lambert, J. The multistage 20 metre shuttle run test for aerobic fitness. J. Sports Sci. 1988, 6, 93–101. [Google Scholar] [CrossRef]
- Hanley, J.A.; McNeil, B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143, 29–36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bundy, V.; Johnson, M.; Gutin, B.; Zhu, H.; Stallmann-Jorgensen, I.; Dong, Y. Adiponectin moderates the relationship between adiposity and leptin in adolescents regardless of gender or race. J. Pediatr. Endocrinol. Metab. 2011, 24, 119–124. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, S.; Liu, R.; Arguelles, L.; Wang, G.; Zhang, J.; Shen, X.; Wang, X. Adiposity trajectory and its associations with plasma adipokine levels in children and adolescents-A prospective cohort study. Obesity 2016, 24, 408–416. [Google Scholar] [CrossRef] [Green Version]
- Sobrinho, C.A.A.; Mendes, E.; Moreira, C.; Abreu, S.; Lopes, L.; Oliveira-Santos, J.; Skurvydas, A.; Mota, J.; Santos, R. Association between Leptin, Adiponectin, and Leptin/Adiponectin Ratio with Clustered Metabolic Risk Factors in Portuguese Adolescents: The LabMed Physical Activity Study. Ann. Nutr. Metab. 2017, 70, 321–328. [Google Scholar] [CrossRef]
- Li, G.; Xu, L.; Zhao, Y.; Li, L.; Fu, J.; Zhang, Q.; Li, N.; Xiao, X.; Li, C.; Mi, J.; et al. Leptin-adiponectin imbalance as a marker of metabolic syndrome among Chinese children and adolescents: The BCAMS study. PLoS ONE 2017, 12, e0186222. [Google Scholar] [CrossRef]
- Finucane, F.M.; Luan, J.; Wareham, N.J.; Sharp, S.J.; O’Rahilly, S.; Balkau, B.; Flyvbjerg, A.; Walker, M.; Højlund, K.; Nolan, J.J.; et al. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 2009, 52, 2345–2349. [Google Scholar] [CrossRef] [Green Version]
- Aldhoon-Hainerová, I.; Zamrazilová, H.; Hill, M.; Hainer, V. Insulin sensitivity and its relation to hormones in adolescent boys and girls. Metabolism 2016, 67, 90–98. [Google Scholar] [CrossRef] [PubMed]
- Paz-Filho, G.; Mastronardi, C.; Wong, M.-L.; Licinio, J. Leptin therapy, insulin sensitivity, and glucose homeostasis. Indian J. Endocrinol. Metab. 2012, 16, S549–S555. [Google Scholar] [CrossRef] [PubMed]
- Yadav, A.A.; Kataria, M.A.; Saini, V.; Yadav, A.A. Role of leptin and adiponectin in insulin resistance. Clin. Chim. Acta 2013, 417, 80–84. [Google Scholar] [CrossRef] [PubMed]
- Ukkola, O.; Santaniemi, M. Adiponectin: A link between excess adiposity and associated comorbidities? J. Mol. Med. 2002, 80, 696–702. [Google Scholar] [CrossRef] [PubMed]
- De Castro Ferreira Vicente, S.E.; Corgosinho, F.C.; da Silveira Campos, R.M.; Masquio, D.C.L.; e Silva, L.O.; Kravchychyn, A.C.P.; de Lima Sanches, P.; de Piano Ganen, A.; Oyama, L.M.; Tock, L.; et al. The impact of adiponectin levels on biomarkers of inflammation among adolescents with obesity. Obes. Med. 2017, 5, 4–10. [Google Scholar] [CrossRef]
- Sargolzaei, J.; Chamani, E.; Kazemi, T.; Fallah, S.; Soori, H. The role of adiponectin and adipolin as anti-inflammatory adipokines in the formation of macrophage foam cells and their association with cardiovascular diseases. Clin. Biochem. 2018, 54, 1–10. [Google Scholar] [CrossRef]
- Thomas, N.E.; Williams, D.R.R. Inflammatory factors, physical activity, and physical fitness in young people. Scand. J. Med. Sci. Sports 2008, 18, 543–556. [Google Scholar] [CrossRef]
Characteristics | Mean (SD) | ||
---|---|---|---|
All (n = 529) | Girls (n = 267) | Boys (n = 262) | |
Age (year) | 14.33 (±1.73) | 14.27 (±1.71) | 14.39 (±1.74) |
Weight (kg) | 55.15 (±12.81) | 53.44 (±11.18) | 56.89 (±14.10) * |
Height (cm) | 160.27 (±9.59) | 157.7 (±6.68) | 162.9 (±11.3) * |
BMI (kg/m2) IOTF | 21.31 ± 3.84 | 21.41 ± 3.96 | 21.20 ± 3.73 |
UW/NW/OW/OB (n) | 24/357/111/37 | 10/181/54/22 | 14/176/57/15 |
UW/NW/OW/OB (%) | 4.5%/67.5%/21%/7% | 3.7%/67.8%/20.3%/8.2% | 5.3%/67.2%/21.8%/5.7% |
Leptin (ng/mL) | 4.12 (± 4.93) | 6.21 (± 5.6) | 1.98 (± 2.85) * |
Ratio Leptin/Adiponectin | 0.43 (±0.67) | 0.62 (± 0.81) | 0.23 (± 0.39) |
Insulin resistance (HOMA-IR) | 3.45 (±5.38) | 3.51 (±1.83) | 3.39 (±7.41) |
KIDMED Index | 7.11 (±2.05) | 7.19 (±1.98) | 7.02 (±2.13) |
20 m shuttle run test (Nr. of laps) | 44.90 (±1.12) | 31.87 (±15.25) | 58.15 (±26.63) * |
AUC | 95% CI | p Value | Cut-Off | Sensitivity (%) | Specificity (%) | ||
---|---|---|---|---|---|---|---|
Girls (n = 267) | Adiponectin (mg/L) | 0.670 | 0.640–0.753 | 0.0005 | ≤8.9 | 54.3 | 76.3 |
Leptin (ng/mL) | 0.700 | 0.640–0.753 | 0.0001 | >5.4 | 77.1 | 63.4 | |
L/A ratio * | 0.736 | 0.679–0.788 | 0.0001 | >0.97 | 54.3 | 89.2 | |
Boys (n = 262) | Adiponectin (mg/L) | 0.603 | 0.541–0.663 | 0.0640 | ≤9.0 | 67.6 | 52.6 |
Leptin (mg/L) ** | 0.806 | 0.753–0.852 | 0.0001 | >1.16 | 85.3 | 62.7 | |
L/A ratio ** | 0.823 | 0.771–0.867 | 0.0001 | >0.35 | 67.6 | 86.8 |
HOMA-IR | Cut-Off | n (%) | OR | 95% CI | p | |
Adiponectin | ||||||
≥8.9 mg/L | 193 (72.3) | 1 | ||||
<8.9 mg/L | 74 (27.7) | Model 1 | 3.92 | (1.86–8.27) | <0.001 | |
Model 2 | 2.87 | (1.26–6.53) | 0.012 | |||
Leptin | ||||||
<5.4 ng/mL | 155 (58.1) | 1 | ||||
≥5.4 ng/mL | 112 (41.9) | Model 1 | 6.18 | (2.61–14.66) | <0.001 | |
Model 2 | 2.99 | (1.10–8.09) | 0.031 | |||
Ratio LA | ||||||
>0.97 | 222 (83.1) | 1 | ||||
≥0.97 | 45 (16.9) | Model 1 | 10.71 | (4.62–24.82) | <0.001 | |
Model 2 | 6.11 | (2.18–17.05) | <0.001 |
HOMA-IR | Cut-Off | n (%) | OR | 95% CI | p | |
Adiponectin | ||||||
≥9.0 mg/L | 131(50.0) | 1 | ||||
<9.0 mg/L | 131(50.0) | Model 1 | 2.40 | (1.10–5.17) | 0.026 | |
Model 2 | 2.08 | (0.88–4.89) | 0.092 | |||
Leptin | ||||||
<1.16 ng/mL | 148(56.5) | 1 | ||||
≥1.16 ng/mL | 114(43.5) | Model 1 | 10.11 | (3.73–27.41) | <0.001 | |
Model 2 | 5.23 | (1.16–17.14) | 0.006 | |||
Ratio LA | ||||||
<−0.35 | 207(79.1) | 1 | ||||
≥−0.35 | 55(21.0) | Model 1 | 13.61 | (5.93–31.24) | <0.001 | |
Model 2 | 8.38 | (2.62–26.81) | <0.001 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Agostinis-Sobrinho, C.; Vicente, S.E.d.C.F.; Norkiene, S.; Rauckienė-Michaelsson, A.; Kievisienė, J.; Dubey, V.P.; Razbadauskas, A.; Lopes, L.; Santos, R. Is the Leptin/Adiponectin Ratio a Better Diagnostic Biomarker for Insulin Resistance than Leptin or Adiponectin Alone in Adolescents? Children 2022, 9, 1193. https://doi.org/10.3390/children9081193
Agostinis-Sobrinho C, Vicente SEdCF, Norkiene S, Rauckienė-Michaelsson A, Kievisienė J, Dubey VP, Razbadauskas A, Lopes L, Santos R. Is the Leptin/Adiponectin Ratio a Better Diagnostic Biomarker for Insulin Resistance than Leptin or Adiponectin Alone in Adolescents? Children. 2022; 9(8):1193. https://doi.org/10.3390/children9081193
Chicago/Turabian StyleAgostinis-Sobrinho, César, Sofia E. de Castro Ferreira Vicente, Sigute Norkiene, Alona Rauckienė-Michaelsson, Justina Kievisienė, Viney Prakash Dubey, Arturas Razbadauskas, Luís Lopes, and Rute Santos. 2022. "Is the Leptin/Adiponectin Ratio a Better Diagnostic Biomarker for Insulin Resistance than Leptin or Adiponectin Alone in Adolescents?" Children 9, no. 8: 1193. https://doi.org/10.3390/children9081193
APA StyleAgostinis-Sobrinho, C., Vicente, S. E. d. C. F., Norkiene, S., Rauckienė-Michaelsson, A., Kievisienė, J., Dubey, V. P., Razbadauskas, A., Lopes, L., & Santos, R. (2022). Is the Leptin/Adiponectin Ratio a Better Diagnostic Biomarker for Insulin Resistance than Leptin or Adiponectin Alone in Adolescents? Children, 9(8), 1193. https://doi.org/10.3390/children9081193